Search Results for keywords:"hexamethylenetetramine"

The U.S. Department of Commerce is delaying the preliminary decisions regarding the investigations into imports of a chemical called hexamethylenetetramine from China, Germany, India, and Saudi Arabia. Originally due by March 10, 2025, these decisions will now be postponed until April 29, 2025. This postponement comes after a request from the petitioner, Bakelite LLC, to allow more time for a thorough review of the information related to the cases. The final determinations will be made 75 days after these new preliminary determinations, unless there is a further delay.

The U.S. Department of Commerce has made a preliminary determination that producers and exporters of hexamethylenetetramine (hexamine) from India are receiving subsidies that can be countervailed. This investigation covers the period from April 1, 2023, to March 31, 2024, with parties invited to comment on the findings. The investigation aligns the final decision on countervailing duties with a separate investigation into whether hexamine is sold at unfairly low prices in the U.S., expected by July 14, 2025. The Department determined a preliminary subsidy rate for the main Indian producer, Kanoria Chemicals, which affects other non-examined companies as well.

The U.S. Department of Commerce has preliminarily determined that subsidies from the government of China are unfairly supporting manufacturers and exporters of hexamethylenetetramine, also known as hexamine. This investigation covers the year 2023, and interested parties can comment on this preliminary finding. Commerce proposes using adverse inferences due to a lack of cooperation from certain respondents and plans to align the final decision in this case with another related investigation set to conclude by July 14, 2025. The findings may affect import duties, as U.S. Customs and Border Protection is directed to suspend liquidation of affected goods.